10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Reduced carboxylesterase 1 is associated with endothelial injury in methamphetamine-induced pulmonary arterial hypertension

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Pulmonary arterial hypertension is a complication of methamphetamine use (METH-PAH), but the pathogenic mechanisms are unknown. Given that cytochrome P450 2D6 (CYP2D6) and carboxylesterase 1 (CES1) are involved in metabolism of METH and other amphetamine-like compounds, we postulated that loss of function variants could contribute to METH-PAH. Although no difference in CYP2D6 expression was seen by lung immunofluorescence, CES1 expression was significantly reduced in endothelium of METH-PAH microvessels. Mass spectrometry analysis showed that healthy pulmonary microvascular endothelial cells (PMVECs) have the capacity to both internalize and metabolize METH. Furthermore, whole exome sequencing data from 18 METH-PAH patients revealed that 94.4% of METH-PAH patients were heterozygous carriers of a single nucleotide variant (SNV; rs115629050) predicted to reduce CES1 activity. PMVECs transfected with this CES1 variant demonstrated significantly higher rates of METH-induced apoptosis. METH exposure results in increased formation of reactive oxygen species (ROS) and a compensatory autophagy response. Compared with healthy cells, CES1-deficient PMVECs lack a robust autophagy response despite higher ROS, which correlates with increased apoptosis. We propose that reduced CES1 expression/activity could promote development of METH-PAH by increasing PMVEC apoptosis and small vessel loss.

          Related collections

          Author and article information

          Journal
          Am J Physiol Lung Cell Mol Physiol
          Am. J. Physiol. Lung Cell Mol. Physiol
          ajplung
          ajplung
          AJPLUNG
          American Journal of Physiology - Lung Cellular and Molecular Physiology
          American Physiological Society (Bethesda, MD )
          1040-0605
          1522-1504
          1 August 2017
          4 May 2017
          1 August 2018
          : 313
          : 2
          : L252-L266
          Affiliations
          [1] 1Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center , Stanford, California;
          [2] 2The Vera Moulton Wall Center for Pulmonary Vascular Medicine, Stanford University Medical Center , Stanford, California;
          [3] 3Stanford Cardiovascular Institute, Stanford University Medical Center , Stanford, California;
          [4] 4University of Illinois College of Medicine, Chicago, Illinois;
          [5] 5Department of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California Davis , Davis, California;
          [6] 6The Vincent Coates Foundation Mass Spectrometry Laboratory, Stanford University , Stanford, California;
          [7] 7Children’s Hospital Helsinki, University of Helsinki , Helsinki, Finland; and
          [8] 8Department of Pathology, Stanford University Medical Center , Stanford, California
          Author notes
          [*]

          R. T. Zamanian and V. de Jesus Perez contributed equally to this work.

          Address for reprint requests and other correspondence: V. A. de Jesus Perez, Div. of Pulmonary and Critical Care Medicine, Stanford University Medical Center, 300 Pasteur Dr., Grant S140b. Stanford, CA 94305 (e-mail: vdejesus@ 123456stanford.edu ).
          Article
          PMC5582936 PMC5582936 5582936 L-00453-2016 L-00453-2016
          10.1152/ajplung.00453.2016
          5582936
          28473326
          21e30c21-b705-4352-ab99-95e02c6f3018
          Copyright © 2017 the American Physiological Society
          Funding
          Funded by: NIH NHLBI K08
          Award ID: HL105884-01
          Funded by: http://doi.org/10.13039/100002291 Pulmonary Hypertension Association (PHA)
          Funded by: http://doi.org/10.13039/100002590 American Lung Association
          Funded by: http://doi.org/10.13039/100000867 Robert Wood Johnson Foundation (RWJF)
          Funded by: http://doi.org/10.13039/100000968 American Heart Association (AHA)
          Funded by: http://doi.org/10.13039/100000066 HHS | NIH | National Institute of Environmental Health Sciences (NIEHS)
          Award ID: R01 ES002710
          Funded by: http://doi.org/10.13039/100000057 HHS | NIH | National Institute of General Medical Sciences (NIGMS)
          Award ID: T32GM099608
          Funded by: NIH
          Award ID: R01 HL134776
          Categories
          Research Article
          Biomarkers in Lung Diseases: From Pathogenesis to Prediction to New Therapies
          Custom metadata
          True

          Comments

          Comment on this article